Back to Search
Start Over
Specific immunological characteristics and risk factor of XBB variants re-infection in nasopharyngeal carcinoma patients after BA.5 infection.
- Source :
-
Virology [Virology] 2024 Sep; Vol. 597, pp. 110142. Date of Electronic Publication: 2024 Jun 28. - Publication Year :
- 2024
-
Abstract
- Objectives: The specific humoral immune response resulting from inactivated vaccination following by BA.5 infection, and predictors of XBB variants re-infection in BA.5 infection-recovered nasopharyngeal carcinoma (BA.5-RNPC) patients, were explored.<br />Methods: Serum SARS-CoV-2 specific antibody levels were assessed using enzyme-linked-immunosorbent-assay. Univariate and multivariate binary logistic regression analyses were conducted to identify factors associated with the magnitude of specific humoral immunity and susceptibility to re-infection by XBB variants.<br />Results: Our data demonstrates that SARS-CoV-2 specific antibody levels were comparable between BA.5-RNPC patients and BA.5 infection-recovered-non-cancerous (BA.5-RNC) individuals. Specifically, serum levels of anti-ancestral-S1-IgG, anti-ancestral-nucleocapsid-protein (NP)-IgG, anti-BA.5-receptor binding domain (RBD)-IgG and anti-XBB.1.1.6-RBD-IgG were higher in BA.5-RNPC patients compared to those without a prior infection. Compared to BA.5-RNPC patients without vaccination, individuals who received inactivated vaccination exhibited significantly higher levels of anti-ancestral-S1-IgG and anti-XBB.1.16-RBD-IgG. Multivariate logistic regression analysis revealed that inactivated vaccination was the most significant predictor of all tested SARS-CoV-2 specific antibodies response. Subsequent analysis indicated that a low globulin level is an independent risk factor for XBB re-infection in BA.5-RNPC patients.<br />Conclusions: The SARS-CoV-2 specific antibodies have been improved in vaccinated BA.5-RNPC patients. However, the baseline immunity status biomarker IgG is an indicators of XBB variant re-infection risk in BA.5-RNPC patients.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Tianxing Ji the behalf of all involved authors.<br /> (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Subjects :
- Humans
Male
Female
Middle Aged
Risk Factors
Adult
Aged
COVID-19 Vaccines immunology
COVID-19 Vaccines administration & dosage
Immunity, Humoral
Vaccines, Inactivated immunology
Vaccines, Inactivated administration & dosage
Antibodies, Viral blood
COVID-19 immunology
COVID-19 virology
Nasopharyngeal Carcinoma immunology
Nasopharyngeal Carcinoma virology
Nasopharyngeal Carcinoma genetics
SARS-CoV-2 immunology
SARS-CoV-2 genetics
Nasopharyngeal Neoplasms immunology
Nasopharyngeal Neoplasms virology
Reinfection immunology
Reinfection virology
Immunoglobulin G blood
Subjects
Details
- Language :
- English
- ISSN :
- 1096-0341
- Volume :
- 597
- Database :
- MEDLINE
- Journal :
- Virology
- Publication Type :
- Academic Journal
- Accession number :
- 38959723
- Full Text :
- https://doi.org/10.1016/j.virol.2024.110142